Literature DB >> 5897354

Chemotherapy for liver cancer by protracted ambulatory infusion.

R D Sullivan, W Z Zurek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5897354

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Bile duct strictures associated with hepatic arterial infusion chemotherapy.

Authors:  R A Clark; T E Gallant
Journal:  Gastrointest Radiol       Date:  1987

2.  Disappearance of hepatic cancer after intra-arterial fluorouracil.

Authors:  J M Anderson; R S Patrick; D W Short; W A Mackey
Journal:  Br Med J       Date:  1972-08-19

3.  One shot administration of antineoplastic agents in massive doses via the celiac artery for inoperable cancer of the liver.

Authors:  Y Kinami; M Hirose; O Takamatu
Journal:  Jpn J Surg       Date:  1972-09

4.  The treatment of jaundice due to liver metastases by quadruple chemotherapy.

Authors:  J Hughes; T A Stoker
Journal:  Postgrad Med J       Date:  1973-04       Impact factor: 2.401

Review 5.  The role of chemotherapy in the treatment of bile duct cancer.

Authors:  R A Oberfield; R L Rossi
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

6.  Vascular access for intra-arterial chemotherapy for nonresectable hepatic tumor.

Authors:  T Kanematsu; K Okadome; H Kohno; T Matsumata; A Kusaba; K Inokuchi
Journal:  Jpn J Surg       Date:  1981

7.  Clinical results of intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of biliary tract cancer.

Authors:  A Hayashibe; M Kameyama
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 8.  Adjuvant treatment of colorectal cancer. Current status and concepts.

Authors:  U F Metzger; B C Ghosh; D L Kisner
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

9.  Results of 27 cases with hepatic metastases treated by combination chemotherapy.

Authors:  T J Priestman; I W Hanham
Journal:  Br J Cancer       Date:  1972-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.